Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P. Inhibition of circulating DPP4 activity in patients with metastatic prostate cancer. Mol Cell Proteomics 2014; 13:3082-3096. PMCID: PMC4223493

Taylor JM, Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P. Aminopeptidase activities as prospective urinary biomarkers for bladder cancer. Proteomics Clinical Applic 2014; 8:317-326. PMCID: PMC4059539

Tempst P. Mass-encoded, synthetic biomarkers and multiplexed urinary monitoring. Clin Chem 2013; 59:1694-1695.

Root A, Allen P, Tempst P*, Yu K*. Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. Cancers (Basel) 2018; 10: 67; doi:10.3390/cancers10030067.

Huang FK, Zhang G, Lawlor K, Nazarian A, Philip J, Tempst P, Dephoure N, Neubert TA. Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res 2017; 16:1121-1132. PMCID: PMC5336479

Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Ghosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Large-scale inter-laboratory study to develop, validate and apply highly complexed, quantitative peptide assays to measure cancer-relevant proteins in plasma. Mol Cell Proteomics 2015; 14:2357-2374. PMCD: PMC4563721

Wilson MD, Harreman M, Taschner M, Reid J, Walker J, Erdjument-Bromage H, Tempst P, Svejstrup JQ. Proteasome-mediated processing of def1, a critical step in the cellular response to transcription stress. Cell 2013; 154:983-995. PMCID: PMC3778974

Oldrini B, Hsieh W-Y, Erdjument-Bromage H, Codega P, Carro MS, Curiel-Garcia A, Campos C, Pourmaleki M, Grommes C, Vivanco I, Rohle D, Bielski CM, Taylor BS, Hollmann TJ, Rosenblum M, Tempst P, Blenis J, Squatrito M, Mellinghoff IK. EGFR Feedback-inhibition by Ran-binding Protein 6 is Disrupted in Cancer. Nature Commun 2017; 8:2035 doi:10.1038/s41467-017-02185-w. PMCID: PMC5725448